111 Inc (YI)
0.6539
-0.03
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
0.6539
0.00 (0.00%)
After-Hours: 18:11
111 Net Income (Quarterly): -1.949M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -1.949M |
March 31, 2024 | -1.925M |
December 31, 2023 | -29.23M |
September 30, 2023 | -12.89M |
June 30, 2023 | -8.167M |
March 31, 2023 | -4.644M |
December 31, 2022 | -16.09M |
September 30, 2022 | -14.14M |
June 30, 2022 | -14.41M |
March 31, 2022 | -17.36M |
December 31, 2021 | -17.40M |
September 30, 2021 | -39.04M |
June 30, 2021 | -24.60M |
March 31, 2021 | -22.60M |
Date | Value |
---|---|
December 31, 2020 | -19.70M |
September 30, 2020 | -15.68M |
June 30, 2020 | -13.08M |
March 31, 2020 | -17.85M |
December 31, 2019 | -22.37M |
September 30, 2019 | -17.57M |
June 30, 2019 | -14.69M |
March 31, 2019 | -17.55M |
December 31, 2018 | -18.21M |
September 30, 2018 | -18.50M |
June 30, 2018 | -13.56M |
March 31, 2018 | -6.594M |
December 31, 2017 | -9.734M |
September 30, 2017 | -9.303M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-39.04M
Minimum
Sep 2021
-1.925M
Maximum
Mar 2024
-16.48M
Average
-16.09M
Median
Dec 2022
Net Income (Quarterly) Benchmarks
Dr Reddy's Laboratories Ltd | 149.84M |
Concord Medical Services Holdings Ltd | -- |
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | -6.965M |
Zai Lab Ltd | -80.28M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 476.09M |
Total Expenses (Quarterly) | 475.63M |
EPS Diluted (Quarterly) | -0.0445 |
Enterprise Value | 121.09M |
Gross Profit Margin (Quarterly) | 6.06% |
Profit Margin (Quarterly) | -0.41% |
Earnings Yield | -86.16% |
Normalized Earnings Yield | -86.38 |